drugset / Trial / NCT01885182
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
To Determine the Safety and Efficacy of Oxycodone / Naloxone Prolonged Release Tablets compared to Oxycodone PR in Subjects with Moderate to Severe, Chronic Cancer Pain
Timeline
- Start
- 2013-06-01
- Primary completion
- 2015-08-30
- Completion
- 2015-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naloxone | Small molecule | 2.5 mg | — |
| Subject | Naloxone | Small molecule | 5 mg | — |
| Subject | Naloxone | Small molecule | 10 mg | — |
| Subject | Naloxone | Small molecule | 20 mg | — |
| Subject | Oxycodone | Other / unclassified | 5 mg | — |
| Subject | Oxycodone | Other / unclassified | 10 mg | — |
| Subject | Oxycodone | Other / unclassified | 20 mg | — |
| Subject | Oxycodone | Other / unclassified | 40 mg | — |